The Valley Desk

NCT01081132 · Interventional trial

Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl

Overall registry status Completed

Phase 3

Conditions Attention-Deficit/Hyperactivity Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov